Abstract | OBJECTIVE: RESULTS: The results of this study demonstrate that DODAC/PHO-S liposomes have exhibited broad cytotoxic potential in B16F10 murine melanoma cells, with significantly greater proportions than treatment with PHO-S. The treatment with the DODAC/PHO-S 2.0 mM liposomal formulation was more efficient in decreasing mitochondrial electrical potential at the same concentrations and treatment time than PHO-S The liposomal formulation DODAC/PHO-S (2.0 mM) was more efficient to promote morphological changes in the cells, without presenting intact lysosomes, at the same time of treatment and concentration as PHO-S Our results demonstrated that the liposomal formulation increased DR4 receptor expression and activated caspases 8 and 3, resulting in the release of cytochrome c in B16F10 tumour cells, when compared to treatment with PHO-S The data obtained prove that the use of DODAC as carrier can maximize the cytotoxic effects of PHO-S This was demonstrated by the translocation of cytochrome c to the cytoplasm and activation of caspase-3 and 8, decreasing the mitochondrial electrical potential and generating morphological changes, in B16F10 cells.
|
Authors | Arthur Cássio de Lima Luna, José Roberto de Assis Santos Filho, Henrique Hesse, Salvador Claro Neto, Gilberto Orivaldo Chierice, Durvanei Augusto Maria |
Journal | BMC research notes
(BMC Res Notes)
Vol. 11
Issue 1
Pg. 126
(Feb 14 2018)
ISSN: 1756-0500 [Electronic] England |
PMID | 29444697
(Publication Type: Comparative Study, Journal Article)
|
Chemical References |
- Adjuvants, Immunologic
- Cytotoxins
- Ethanolamines
- Liposomes
- Quaternary Ammonium Compounds
- dimethyldioctadecylammonium
- phosphorylethanolamine
|
Topics |
- Adjuvants, Immunologic
(pharmacology)
- Animals
- Apoptosis
(drug effects)
- Cell Line, Tumor
- Cytotoxins
(pharmacology)
- Ethanolamines
(pharmacology)
- Liposomes
(pharmacology)
- Melanoma, Experimental
(drug therapy)
- Mice
- Mitochondria
(drug effects)
- Nanotechnology
- Quaternary Ammonium Compounds
(pharmacology)
|